Semaglutide
Also known as: GLP-1 receptor agonist
Classification
Peptide
Regulatory Status
unknown
Overview
Mechanism has not been reviewed for this draft record.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pilot regulatory evidence packet requires human review before publication. | Compiled draft requires human review before publication.
Sources
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e6da837c-0da0-41d6-973c-5559bf764367 (opens in a new tab)
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b (opens in a new tab)
- https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss (opens in a new tab)
Educational reference only — not medical advice.